Dec 8, 2015 by Brian FeroldiInstant Analysis: Alexion Pharmaceuticals Inc Wins an Important FDA ApprovalInvestors cheer an important FDA win.
Dec 8, 2015 by Brian FeroldiWhy TherapeuticsMd Inc Investors Are Rejoicing TodayPositive Phase 3 clinical data related to its lead compound sends shares skyrocketing.
Dec 7, 2015 by Brian FeroldiWhy Dyax Corp Rocketed 22% Higher in NovemberA buyout offer from a rival firm has Dyax shareholders seeing green.
Dec 7, 2015 by Brian FeroldiAlnylam Pharmaceuticals is Selling Off Today -- But Why?Despite releasing positive clinical data the stock still manages to sell off.
Dec 7, 2015 by Brian Feroldi, Jason Hall, Matt Frankel, CFP, Jordan Wathen, and Adam GalasSafe Stocks Yielding 5% (or More) Do Exist -- Here Are 5 of ThemLooking for a high yield and low risk? If so then our contributors think that these 5 stocks should be on your radar.
Dec 7, 2015 by Brian FeroldiLast Week's Best Healthcare ETFIt was an ugly week to hold healthcare stocks, but this exchange-traded fund held up the the best. Here's why.
Dec 6, 2015 by Brian FeroldiZogenix Zoomed Higher in November -- Here's Why An earnings report that exceeded expectations sent shares of this clinical stage biopharma higher.
Dec 5, 2015 by Brian FeroldiWhy Halozyme Therapeutics Inc. Jumped 13% in NovemberInvestors look past an earnings miss to push shares of the small-cap biotech higher.
Dec 4, 2015 by Brian FeroldiWhy Karyopharm Therapeutics Jumped in NovemberA lower-than-expected loss mixed with clinical progress send shares higher.
Dec 4, 2015 by Brian FeroldiOcata Therapeutics Almost Doubled in November -- Here's WhyA buyout offer sends shares of this former penny stock soaring higher.
Dec 4, 2015 by Brian FeroldiWhy Relypsa Inc Is Skyrocketing TodayThe rumor mill is buzzing about a potential takeover, causing shares to go higher.
Nov 30, 2015 by Brian Feroldi, Sean Williams, and Cheryl SwansonWhere Will Gilead Sciences Be in 10 Years?Gilead Sciences has been a terrific stock to hold over the past 10 years, but what will this company look like a decade from now?
Nov 30, 2015 by Brian FeroldiLast Week's Top Healthcare ETFHealthcare stocks in general had another good week, but one exchange traded fund in particular performed exceptionally well.
Nov 26, 2015 by Brian FeroldiGilead Sciences Grabs 4 Regulatory Wins -- but Does It Matter?Gilead Sciences has announced four new regulatory approvals since the start of the quarter, but will they move the company's financials?
Nov 23, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Dividend Stocks You Don't Have to BabysitLooking for a few dividend-paying stocks that don't require constant attention? You might want to give these three names a hard look.
Nov 22, 2015 by Brian FeroldiSanofi Sets Its Sights on 2020 -- Here's What Investors Need to KnowThe company provides its investors with a strategic roadmap that it believes will get its stock back on track.
Nov 22, 2015 by Brian Feroldi, Sean Williams, and Todd Campbell3 Biotech Stocks to Buy in DecemberAre you interested in putting a few biotech stocks on your holiday wish list? Our contributors think you should give these three names a look.
Nov 21, 2015 by Brian Feroldi, Todd Campbell, and George Budwell, PhD3 Healthcare Stocks You Don't Have to BabysitLooking for a healthcare-related stock that won't require your constant attention? Our contributors think that these three stocks should be on your radar.
Nov 20, 2015 by Brian FeroldiThe Best Healthcare ETF of the WeekThis healthcare ETF outperformed the overall market this week. Lets break down why.
Nov 20, 2015 by Brian FeroldiWhy Sarepta Therapeutics Inc Is Soaring TodayA harsh FDA report related to Sarpeta's primary competitor sends shares screaming higher.
